Physician profile
Kelli Porter
NPI 1205836624
$1,642.47
in general payments reported to CMS, 2019-2025
18 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Women'S Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $634 · 2022: $341 · 2023: $298 · 2024: $134 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636 · Education: $30.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.47 |
| Education | $30.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $733.48 | 2021-2023 | |
| Avion Pharmaceuticals | $189.97 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $180.75 | 2022-2025 | |
| Novo Nordisk INC | $106.47 | 2023-2025 | Wegovy |
| Pfizer INC. | $67.67 | 2021-2023 | |
| Hologic Sales and Service, LLC | $48.76 | 2025 | Aptima |
| Myovant Sciences INC. | $41.23 | 2021 | |
| Astellas Pharma US INC | $37.15 | 2024 | Veozah |
| Millicent US INC | $36.51 | 2021-2024 | |
| Organon LLC | $34.49 | 2021-2024 | |
| Ethicon US, LLC | $28.82 | 2025 | Vistaseal |
| Therapeuticsmd, INC. | $27.10 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $26.48 | 2025 | Gemtesa |
| Revance Therapeutics, INC. | $21.80 | 2025 | Daxxify |
| Bayer Healthcare Pharmaceuticals INC. | $17.83 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.85 | 2021 | |
| Coopersurgical, INC. | $14.92 | 2021 | |
| Aspira Women'S Health INC | $12.19 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.